Trademark: 90898772
Word
DAIM
Status
Registered
Status Code
700
Status Date
Tuesday, November 22, 2022
Serial Number
90898772
Registration Number
6904558
Registration Date
Tuesday, November 22, 2022
Mark Type
4000
Filing Date
Tuesday, August 24, 2021
Published for Opposition
Tuesday, September 6, 2022

Trademark Owner History
Daim Pharma Ltd - Original Registrant

Classifications
5 Vaccines; Chemical preparations for the diagnosis of diabetes; Pharmaceutical preparations for the prevention of diabetes; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for the prevention of diseases of the immune system; Pharmaceutical preparations for the prevention of disorders of the immune system; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of autoimmune diseases; Pharmaceutical preparations for the prevention of autoimmune diseases; Pharmaceutical preparations for the treatment of autoimmune disorders; Pharmaceutical preparations for the prevention of autoimmune disorders; Pharmaceutical preparations for regulating the immune system; all of the aforesaid goods being for the diagnosis, treatment, management or prevention of Type 1 diabetes
35 Advertising services relating to pharmaceuticals for the treatment of diabetes; Advertising services relating to pharmaceuticals; Advertising, marketing and promotional services; Advertising; Advertising services to promote public awareness of medical conditions; Advertising services related to immune disorders; Advertising services related to autoimmune diseases; all of the aforesaid services being provided in connection with the diagnosis, treatment, management or prevention of Type 1 diabetes
44 Diabetes screening services; Medical services in the field of diabetes; Providing information via the Internet in the field of diabetes; Medical screening; Health screening services in the field of diabetes; Medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Medical services for the diagnosis of conditions of the human body; Medical services; Medical diagnostic testing services; Medical services for the treatment of conditions of the human body; Medical testing services relating to the diagnosis and treatment of disease; Performing diagnosis of diseases; Medical information services provided via the Internet; Providing medical information; Medical analysis services for autoimmune disease diagnosis and prognosis; all of the aforesaid services relating to the diagnosis, treatment, management or prevention of Type 1 diabetes
10 Medical test kits for diabetes monitoring for home use; Testing instruments for medical diagnostic purposes, namely, monitoring glucose level; Blood glucose testing apparatus; Apparatus for carrying-out diagnostic tests for medical purposes, namely, for diabetes testing; Diagnostic, examination, and monitoring equipment, namely, blood glucose monitor; Medical apparatus for testing the level of glucose in the blood; Medical apparatus and instruments for monitoring glucose levels; Medical diagnostic instruments for measuring glucose levels in blood; Medical testing instruments for recording blood glucose levels; all of the aforesaid goods being for use in the diagnosis, treatment, management or prevention of Type 1 diabetes

Trademark Events
Nov 22, 2022
Notice Of Registration Confirmation Emailed
Nov 22, 2022
Registered-Principal Register
Sep 6, 2022
Official Gazette Publication Confirmation E-Mailed
Sep 6, 2022
Published For Opposition
Aug 17, 2022
Notification Of Notice Of Publication E-Mailed
Aug 1, 2022
Approved For Pub - Principal Register
Aug 1, 2022
Examiner's Amendment Entered
Aug 1, 2022
Notification Of Examiners Amendment E-Mailed
Aug 1, 2022
Examiners Amendment E-Mailed
Aug 1, 2022
Examiners Amendment -Written
Jul 20, 2022
Teas/Email Correspondence Entered
Jul 20, 2022
Correspondence Received In Law Office
Jul 19, 2022
Assigned To Lie
Jun 30, 2022
Teas Response To Office Action Received
Jun 7, 2022
Notification Of Non-Final Action E-Mailed
Jun 7, 2022
Non-Final Action E-Mailed
Jun 7, 2022
Non-Final Action Written
May 26, 2022
Assigned To Examiner
Oct 10, 2021
New Application Office Supplied Data Entered In Tram
Aug 27, 2021
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24